Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines

Add time:08/22/2019    Source:sciencedirect.com

We screened a series of 4-anilinoquinolines and 4-anilinoquinazolines and identified novel inhibitors of Mycobacterium tuberculosis (Mtb). The focused 4-anilinoquinoline/quinazoline scaffold arrays yielded compounds with high potency and the identification of 6,7-dimethoxy-N-(4-((4-methylbenzyl)oxy)phenyl)quinolin-4-amine (34) with an MIC90 value of 0.63-1.25 µM. We also defined a series of key structural features, including the benzyloxy aniline and the 6,7-dimethoxy quinoline ring, that are important for Mtb inhibition. Importantly the compounds showed very limited toxicity and scope for further improvement by iterative medicinal chemistry.

We also recommend Trading Suppliers and Manufacturers of N-(4-BENZYLOXY-PHENYL)-2-CHLORO-ACETAMIDE (cas 19514-92-2). Pls Click Website Link as below: cas 19514-92-2 suppliers

Prev:Invited paperThe photophysical studies of Pluronic F127/P123 micelle mixture system loaded with metal free and Zn 5,10,15,20-tetrakis[4-(benzyloxy) phenyl]porphyrins
Next:Novel approach toward the morphine skeleton. Synthesis of 1-(5-benzyloxy-2-bromo-4-methoxybenzyl)-6-oxo-3,4,6,7,8,8a-hexahydro-1H-isoquinoline-2-carboxylic acid phenyl ester via N-acylpyridinium salt chemistry)